Eye Drop Trial for Retinal Diseases

A clinical trial has commenced across Australia for a novel eye drop treatment that could improve the treatment of patients with retinal vascular diseases. If successful, the eye drops will revolutionise treatment for diabetic macular oedema and wet age-related macular degeneration, which currently involves serial injections of an antibody into the back of the eye. Based on initial work carried out at the UNSW School of Chemistry, Professor Jonathan Morris collaborated with Exonate Limited to design the molecule used in the trial.

Read the full article here

Tags